Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA’s share price has been extremely volatile amid its strategic shifts. According to market data, BNBX closed at $3.42 on Oct. 21 marketscreener.com. It then jumped after hours on Oct. 22 with news of the PIPE closing, trading around $4.49 by 8:43 AM EDT on Oct. 22 benzinga.com. This recent pop follows a 31.62% surge on Oct. 6 when Nasdaq officially changed its symbol to BNBX nasdaq.com. Earlier in October the stock briefly spiked near $5.85 on Oct. 6 tipranks.com. In summary, BNBX has climbed from the low-$3’s to the mid-$4’s over the past week, reflecting enthusiasm around the crypto funding news.
Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus stock had been riding a wave of positive sentiment through October 2025. On Oct 21 it closed at $23.16 – its highest level in a year marketbeat.com – following stronger-than-expected Q2 results. However, on Oct 22 the company’s interim cystic fibrosis data triggered a dramatic sell-off. Investing.com reported that ARCT fell about 50% as investors digested the mixed news ng.investing.com. By pre-market trading the next day it was down over 60% at roughly $9 benzinga.com. MarketBeat confirmed that Guggenheim downgraded the stock to Neutral on Oct 22 marketbeat.com. Overall, analysts remain divided: the consensus remains a “Moderate Buy” with targets around $50 marketbeat.com, but rating changes range from Zacks’ recent upgrade to “Strong Buy” to a few bearish views.
22 October 2025
Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Benficient stock closed Oct 21 at ~$0.49 and jumped ~64% to ~$0.80 after hours when Chairman Thomas O. Hicks and Interim CEO James Silk converted $52.6 M of preferred units into Class A shares investing.com benzinga.com. The company is racing to meet Nasdaq’s listing rules. Q1 FY2026 results showed heavy losses but CEO Silk emphasized cost cuts and new capital deals to rebuild cash globenewswire.com scr.zacks.com. Zacks maintains a $2.00 price target, implying ~300% upside scr.zacks.com, though ChartMill notes serious financial weakness chartmill.com.
22 October 2025
Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Corporation shares surged after its Oct. 21 Q3 report, reaching ~$67.82 intraday on Oct. 21 Marketbeat. The stock is up roughly 30–35% year-to-date and opened Oct 22 near $65–66. Q3 revenue was $110.4 M and EPS $0.63, crushing analyst expectations Investing Marketbeat. Analyst firms upgraded VICR to Buy with ~$90 price targets, citing strong growth in high-margin IP licensing and next-gen power products Gurufocus Intellectia. Investors are excited by Vicor’s role in AI and data-center power, its recently announced ~$300 M licensing agreements stemming from a U.S. import ban on copycat products Vicorpower Gurufocus, and the launch of new “Vertical Power Delivery” modules that cram ~10 kW in an iPhone-sized package Ainvest Gurufocus. Vicor’s market cap is ~$2.9 B, and it maintains a very cash-rich, zero-debt balance sheet with ~$362 M cash Investing Gurufocus.
AST SpaceMobile Stock Shoots for the Stars – Verizon Deal and Satellite Breakthroughs Ignite 300% Rally

AST SpaceMobile Stock Shoots for the Stars – Verizon Deal and Satellite Breakthroughs Ignite 300% Rally

AST SpaceMobile’s stock has been one of 2025’s hottest stories. After trading around $30 in late 2024, ASTS rallied over 300% this year on a wave of positive news ts2.tech ts2.tech. In early October the stock broke out of the $40s on back-to-back ~16% jumps ts2.tech, hitting all-time highs above $74.77 ts2.tech. This month’s catalyst was a partnership announcement with Verizon, which helped ASTS reach an intraday record near $100 ts2.tech. However, volatility has emerged: a dilutive share offering in early October caused a 6% pullback ts2.tech, and a $575M convertible debt raise pressured the stock. By Oct 21 ASTS settled at $78.61 stockinvest.us, still well above its year-ago level.
22 October 2025
Will SBEV Pop or Flop? Splash Beverage Group Stock Surges on Big Deals – Analysts Weigh In

Will SBEV Pop or Flop? Splash Beverage Group Stock Surges on Big Deals – Analysts Weigh In

Splash Beverage Group stock has seen dramatic swings in 2025. After trading under $1 for much of early 2025, the shares climbed steeply in the spring, peaking above $13.50. By late October however, SBEV sits around $1.9, down significantly from the highs. Year-to-date it’s up roughly 70%, but this masks wild volatility: for example, a single day move of -22% on April 7 and a +38% jump on June 26 can be seen in the trading record.
22 October 2025
VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

On Oct. 21 VSee Health stunned the market by announcing a landmark teleradiology services agreement with a major Level-1 trauma hospital system. The multi-year deal – which began service in June – is valued at roughly $10 million over two years, with additional $5+ million in potential bonuses for meeting volume targets streetinsider.com financialcontent.com. Management says it will double the company’s annual recurring revenue, a milestone that co-CEO Dr. Imo Aisiku hailed as “just the beginning.” In a press statement he called the deal “a game-changer for VSee Health and our shareholders,” saying it “opens doors to a pipeline of future contracts” streetinsider.com ts2.tech.
22 October 2025
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific posted reported net income of $755 M and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter of strong performance” prnewswire.com, fueled by robust growth across all businesses. Total sales were $5.065 B, up 20.3% from a year ago prnewswire.com. Importantly, organic revenue grew 15.3%, well above the 12–14% guidance range. U.S. revenues surged ~27% in Q3 investing.com, reflecting strong demand for its interventional cardiology and MedSurg devices.
22 October 2025
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo’s stock slide accelerated this week amid a dramatic boardroom conflict. On Oct. 21, the Novo Nordisk Foundation announced it would remove chair Helge Lund and six other independent directors. A Reuters report noted that this “boardroom coup” came amid disagreement over strategy and a push for “a sharper focus on the key U.S. market to revive sales” reuters.com reuters.com. Former CEO Lars Rebien Sørensen is set to take over as chair for 2–3 years reuters.com.
Thermo Fisher Stock Skyrockets – Biotech Boom & Big Deals Fuel Rally, Analysts Eye $650

Thermo Fisher Stock Skyrockets – Biotech Boom & Big Deals Fuel Rally, Analysts Eye $650

Thermo Fisher’s stock price has surged in recent weeks on renewed investor optimism. After a slow start to 2025, the stock turned higher in October. TS2.Tech notes the stock “rallied strongly in recent weeks – up over 11% in October after a slower start to the year” ts2.tech. On Oct. 1, Thermo Fisher jumped about +9.8% as healthcare stocks rallied following a U.S. drug-pricing deal markets.financialcontent.com. The sector’s strength continued into early October: Biogen climbed +10.9% and Thermo +9.4% on Oct. 1 ts2.tech, and TMO again spiked around Oct. 6 amid a broad biotech upswing ts2.tech.
22 October 2025
Vertiv (VRT) Stock Soars on AI Data-Center Boom and Blowout Q3 – Can the Rally Last?

Vertiv (VRT) Stock Soars on AI Data-Center Boom and Blowout Q3 – Can the Rally Last?

Vertiv’s stock has been on a tear. After years of steady growth, the share price accelerated in summer 2025 amid booming AI and data-center demand ts2.tech. By Oct. 9 the stock briefly reached a 52-week high near $180 ts2.tech. As of Oct. 22 it sits in the mid-$170s ts2.tech. Trading volume spiked on the heels of earnings news; for example, Vertiv jumped over 5% on Oct. 10 alone.
Oklo Stock Soars 500% on $2B Nuclear Fuel Deal – Breakthrough or Bubble?

Oklo Stock Soars 500% on $2B Nuclear Fuel Deal – Breakthrough or Bubble?

Oklo Inc. is a California-based advanced nuclear startup whose stock has surged about 500–650% in 2025 finviz.com ts2.tech. It went public via a SPAC with Sam Altman’s AltC Acquisition in May 2024, raising ~$306 million oklo.com reuters.com. In mid-October 2025 Oklo announced a major fuel partnership: Europe’s newcleo will invest up to $2 billion to build advanced nuclear fuel factories in the U.S. oklo.com investorsobserver.com. The company has also inked 20-year power purchase agreements to supply clean power to oil producer Diamondback Energy and data-center firm Wyoming Hyperscale datacenterfrontier.com oklo.com. U.S. government support has been strong – Oklo was chosen for two DOE pilot programs and is working toward NRC licensing of its first “Aurora” reactor ts2.tech. Analysts remain mixed: the consensus 12-month price target is well below the current trading price ts2.tech, reflecting both bullish forecasts and warnings that Oklo is an early-stage, pre-revenue play ts2.tech investorsobserver.com.
GM Stock Skyrockets 15% on Earnings Beat – EV Pivot & Tariff Tailwinds

GM Stock Skyrockets 15% on Earnings Beat – EV Pivot & Tariff Tailwinds

General Motors stunned investors with better-than-expected third-quarter 2025 results, triggering a huge stock pop. GM reported $2.80 adjusted EPS on roughly $48.6 B in revenue ts2.tech. The market had feared a big hit from tariffs and slowing demand, but GM’s cost controls and premium pricing offset lower volumes. After the results, GM raised its full-year guidance sharply – now forecasting $9.75–$10.50 EPS and $12–$13 B EBIT for 2025 ts2.tech. Analysts note GM achieved this by “delivering on commitments” and finding efficiencies even amid market shifts ts2.tech.
AT&T Beats Q3 Forecast with 405K New Subs – Is Its 5G Bet Paying Off?

AT&T Beats Q3 Forecast with 405K New Subs – Is Its 5G Bet Paying Off?

In its Oct. 22 earnings release, AT&T reported solid Q3 results highlighted by strong subscriber growth, even as revenue growth stayed modest. The telecom giant earned $30.7 billion in revenue and GAAP EPS of $1.29 prnewswire.com. Adjusted EPS was $0.54, in line with analyst estimates prnewswire.com. Crucially, AT&T added 405,000 postpaid wireless customers in Q3, far above the ~334,000 additions analysts had expected reuters.com. This subscription surge drove AT&T’s stock up about 4% in pre-market trading reuters.com. The results underscore the resilience of AT&T’s core wireless and broadband businesses.
22 October 2025
Bahrain’s First Solar Power Plant: 150MW Tender to Power 6,300 Homes & Slash 100,000t CO₂

Bahrain’s First Solar Power Plant: 150MW Tender to Power 6,300 Homes & Slash 100,000t CO₂

Bahrain’s EWA formally launched the tender on Oct. 16, 2025 for the kingdom’s first utility-scale PV plant renewablesnow.com. President Kamal bin Ahmed Mohammed called it “one of the most prominent strategic projects” for Bahrain’s clean energy push renewablesnow.com. The detailed tender documents specify a Bilaj Al Jazayer Solar IPP of at least 100 MWac, allowing scale up to the originally announced 150 MW. Bids from experienced developers are due by Dec 28, 2025 taiyangnews.info. The winning bidder will sign a long-term power purchase/operation deal under a Build-Own-Operate model pv-tech.org taiyangnews.info. In practice, the private developer must finance the project upfront, build and maintain it, and handle grid connection – with Bahrain buying the power.
Boeing Wins $461M US Army Chinook Deal – Heavy-Lift Boost and Stock Surge

Boeing Wins $461M US Army Chinook Deal – Heavy-Lift Boost and Stock Surge

On Oct. 21 Boeing confirmed it won two Army contracts to produce nine CH-47F Block II helicopters reuters.com marketscreener.com. The awards are valued at $461 million and “bring the total number of Block II aircraft under contract to 18” reuters.com marketscreener.com. Boeing spokesman Heather McBryan emphasized that “the rapid succession of contracts indicates that the Chinook will continue to play an important role in the U.S. Army’s family-of-systems, particularly in a contested logistics environment” marketscreener.com. Boeing delivered the first Block II aircraft in mid-2024 and six total are now undergoing evaluations with the Army marketscreener.com. The new deals follow the Army’s Sept. 30 decision to accelerate Block II fielding using FY2025–26 funds aerotime.aero army.mil.
22 October 2025
Winn-Dixie’s Big Rebrand: Grocer Abandons Alabama to Focus on Florida Boom

Winn-Dixie’s Big Rebrand: Grocer Abandons Alabama to Focus on Florida Boom

On Oct. 21, Southeastern Grocers announced it will drop the Southeastern Grocers name and unify under the Winn-Dixie brand in early 2026, concentrating on its Florida market grocerydive.com pulseratings.com. In a press release Hucker explained, “For a century, Winn-Dixie has proudly called Florida home… as we enter our next century as The Winn-Dixie Company… we are accelerating growth where our roots run deepest” businesswire.com. The plan is to pump capital into Florida stores – remodeling dozens, expanding liquor stores, and improving customer services businesswire.com mainstreetdailynews.com.
22 October 2025
GE Vernova Stock Poised for Explosive Rally After $5.3B Deal and AI-Powered Energy Boom

GE Vernova Stock Poised for Explosive Rally After $5.3B Deal and AI-Powered Energy Boom

GE Vernova – the energy spinoff of GE – is set to report Q3 results on Oct. 22 amid a flurry of bullish catalysts. The company announced on Oct. 21 it will pay $5.275 billion for the remaining 50% of transformer maker Prolec GE, fueling its fastest-growing Electrification segment gevernova.com reuters.com. At the same time, GE Vernova’s nuclear division struck a global alliance with Samsung/Hitachi to deploy its 300 MWe BWRX-300 small modular reactor – including a proposed five-unit deal in Sweden ts2.tech ts2.tech. These deals come as U.S. power demand is surging – the U.S. Energy Information Administration projects record electricity use in 2025–26 reuters.com. Analysts expect Q3 sales around $9.18–9.97 billion and EPS ~$1.78 nasdaq.com investing.com, but they’ll be watching GE Vernova’s huge order backlog and margin outlook closely investing.com gevernova.com. The stock has already climbed nearly 80–100% YTD, hitting ~52-week highs near $677 before a recent pullback. Sentiment is largely positive – Susquehanna upgraded its 12-month target to $740 and Barclays to $706 marketbeat.com – and consensus is a “Moderate Buy” marketbeat.com.
Palantir (PLTR) Rockets 300% on AI Frenzy – Analysts Sound Bubble Alarm

Palantir (PLTR) Rockets 300% on AI Frenzy – Analysts Sound Bubble Alarm

With Q3 earnings looming, investors will watch whether Palantir can sustain this torrid pace or if profit-taking ensues. The company’s defense and AI momentum is real – Saxo’s Jacob Falkencrone notes Palantir is “becoming an indispensable partner for enterprises in the AI revolution” reuters.com – but the stock’s stratospheric run also leaves little margin for error. As one strategist put it, “the stock is trading at what is frankly an absolutely wild valuation”, so any slowdown or market rotation could trigger a sharp pullback qz.com.
Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device

Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device

Astronauts face rapid muscle and bone loss in zero gravity, so Hungary’s new space traveler Kapu built an astronaut-specific fitness program. As BTL’s press release explains, EMSCULPT NEO was added to Kapu’s intensive training to counteract the muscle atrophy of orbit prnewswire.com. “Studies show astronauts lose up to 30% of muscle mass in orbit,” notes Dr. Nóra Sydó of Budapest’s Semmelweis University, who led Kapu’s training prnewswire.com. Dr. Sydó – also doctor to Hungary’s Olympic swim team – reports that with EMSCULPT NEO, medical tests showed “muscle hypertrophy, improved body composition and increased cardiopulmonary fitness” beyond what standard workouts achieved prnewswire.com. In effect, the device delivered a simulated high-rep workout: pulsed electromagnetic and RF energy cause muscles to contract reflexively, giving an extra “boost” to strength and endurance without extra time on the treadmill.
22 October 2025
1 90 91 92 93 94 164

Stock Market Today

  • Top U.S. Banking Figure Puts Emphasis on Five Stocks Instead of Broader Market
    July 26, 2026, 10:06 AM EDT. With the S&P 500 reflecting expectations of a favorable scenario yet leaving little room for error, investors are encouraged to look to the TOLL+M investment model to cope with persistent high rates and the index's rich valuations. Attention is moving away from the overall market to spotlight five particular stocks.